Opaleye Management Inc. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$6,979,000
-7.2%
205,3810.0%1.30%
+4.4%
Q2 2021$7,519,000
-24.5%
205,381
-7.5%
1.25%
-14.6%
Q1 2021$9,954,000
-21.4%
222,0000.0%1.46%
-11.7%
Q4 2020$12,670,000
+11.2%
222,0000.0%1.66%
-25.7%
Q3 2020$11,389,000
-12.9%
222,0000.0%2.23%
-15.7%
Q2 2020$13,081,000
+43.1%
222,0000.0%2.64%
+9.1%
Q1 2020$9,140,000
-34.6%
222,000
-1.1%
2.42%
-11.7%
Q4 2019$13,973,000
+79.0%
224,500
-2.4%
2.74%
-2.9%
Q3 2019$7,806,000
+11.7%
230,000
-25.8%
2.82%
+32.5%
Q2 2019$6,991,000
-11.4%
310,000
-8.8%
2.13%
-2.5%
Q1 2019$7,891,000
+10.6%
340,0000.0%2.18%
-17.9%
Q4 2018$7,136,000
-56.1%
340,000
-19.0%
2.66%
-35.6%
Q3 2018$16,262,000
-1.6%
420,0000.0%4.14%
-3.3%
Q2 2018$16,527,000
+126.0%
420,000
+15.1%
4.28%
+104.6%
Q1 2018$7,314,000
+77.5%
365,000
+68.2%
2.09%
+43.5%
Q3 2017$4,120,000217,0001.46%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 4,104,140$93,041,00043.52%
SV Health Investors, LLC 1,716,303$38,909,00020.55%
PURA VIDA INVESTMENTS, LLC 68,154$1,545,0000.65%
Redmile Group, LLC 683,880$14,658,0000.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 77,000$1,746,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 224,154$5,008,0000.59%
EMERALD ADVISERS, LLC 482,626$10,941,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 416,342$9,438,0000.38%
Orbimed Advisors 1,176,070$26,662,0000.34%
VIKING GLOBAL INVESTORS LP 2,394,625$54,286,0000.33%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders